Overview
Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancy
Status:
Completed
Completed
Trial end date:
2000-07-01
2000-07-01
Target enrollment:
Participant gender: